Uxin CEO's Entity Adopts 10b5-1 Plan for $5M Stock Purchase with $2.85 Price Cap, Purchases Start Sept 28
UXIN is trading near its 52-week low of $1.42 (12% above the low).
Summary
Uxin's CEO, Kun Dai, through an entity he controls, has adopted a Rule 10b5-1 plan to purchase up to $5 million of the company's ADSs, with purchases authorized to begin on September 28, 2026, at a price no higher than $2.85 per ADS.
Key Events · Ownership and Investor Activity · UXIN
-
10b5-1 Purchase Plan Adopted
Xin Gao Group Limited, an entity controlled by CEO Kun Dai, has adopted a pre-arranged trading plan under Rule 10b5-1.
-
Up to $5 Million in Stock Purchases
The plan authorizes the purchase of up to US$5 million of the company's American Depositary Shares.
-
Purchase Price Cap and Start Date
Purchases will be executed only if the price is no more than US$2.85 per ADS and are authorized to commence on September 28, 2026, following a 90-day cooling-off period.
Analysis · UXIN · Trade & Services
This filing formalizes the previously announced intent by Uxin's CEO, Kun Dai, to purchase up to $5 million in company stock. The adoption of a Rule 10b5-1 plan provides a structured framework for these purchases, setting a maximum price of $2.85 per ADS. While the plan indicates continued confidence from the CEO, the pre-arranged nature and the delayed commencement date (September 28, 2026) due to the cooling-off period mean it is not an immediate open-market buy, which typically carries a stronger signal.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 29.5% of the 1629 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.59%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, UXIN was trading at $1.58 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $330M. The 52-week trading range was $1.42 to $5.36. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.